Paper · 32905132
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 50
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27036991 | Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial. | Lancet HIV | 2016 | https://conductscience.org/library/papers/27036991 | PubMed |
| 2 | 11950737 | Drug points: Neuropsychiatric complications of nevirapine treatment. | BMJ | 2002 | https://conductscience.org/library/papers/11950737 | PubMed |
| 3 | 24370963 | Whoonga and the abuse and diversion of antiretrovirals in Soweto, South Africa. | AIDS Behav | 2014 | https://conductscience.org/library/papers/24370963 | PubMed |
| 4 | 14731163 | Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitors. | HIV Med | 2004 | https://conductscience.org/library/papers/14731163 | PubMed |
| 5 | 25350958 | Dolutegravir: clinical and laboratory safety in integrase inhibitor-naive patients. | HIV Clin Trials | 2014 | https://conductscience.org/library/papers/25350958 | PubMed |
| 6 | 26555069 | Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV. | PLoS One | 2015 | https://conductscience.org/library/papers/26555069 | PubMed |
| 7 | 23702798 | The HIV antiretroviral drug efavirenz has LSD-like properties. | Neuropsychopharmacology | 2013 | https://conductscience.org/library/papers/23702798 | PubMed |
| 8 | 19732926 | Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda. | Trans R Soc Trop Med Hyg | 2010 | https://conductscience.org/library/papers/19732926 | PubMed |
| 9 | 19187258 | Valacyclovir neurotoxicity: clinical experience and review of the literature. | Eur J Neurol | 2009 | https://conductscience.org/library/papers/19187258 | PubMed |
| 10 | 28442915 | Efficacy and safety outcomes of sofosbuvir-based treatment regimens for hepatitis C virus-infected patients with or without cirrhosis from phase III clinical trials. | Ther Clin Risk Manag | 2017 | https://conductscience.org/library/papers/28442915 | PubMed |
| 11 | 25977241 | Safety, efficacy and indications of prescription of maraviroc in clinical practice: Factors associated with clinical outcomes. | Antiviral Res | 2015 | https://conductscience.org/library/papers/25977241 | PubMed |
| 12 | 26788406 | Comparison of Antiretroviral Regimens: Adverse Effects and Tolerability Failure that Cause Regimen Switching. | Infect Chemother | 2015 | https://conductscience.org/library/papers/26788406 | PubMed |
| 13 | 15307035 | Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV-infected adults initiating protease inhibitor-containing therapy. | Clin Infect Dis | 2004 | https://conductscience.org/library/papers/15307035 | PubMed |
| 14 | 16062101 | Acute dystonia induced by lamivudine. | Clin Neuropharmacol | 2005 | https://conductscience.org/library/papers/16062101 | PubMed |
| 15 | 23955659 | Whoonga: potential recreational use of HIV antiretroviral medication in South Africa. | AIDS Behav | 2014 | https://conductscience.org/library/papers/23955659 | PubMed |
| 16 | 1827127 | Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism. | J Clin Endocrinol Metab | 1991 | https://conductscience.org/library/papers/1827127 | PubMed |
| 17 | 26356545 | Patient Characteristics, Safety, and Tolerability with Telaprevir Treatment for HCV in the Clinic: a Retrospective, Multicenter Study. | J Clin Transl Hepatol | 2014 | https://conductscience.org/library/papers/26356545 | PubMed |
| 18 | 21412057 | Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection. | AIDS | 2011 | https://conductscience.org/library/papers/21412057 | PubMed |
| 19 | 16287792 | Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals. | Ann Intern Med | 2005 | https://conductscience.org/library/papers/16287792 | PubMed |
| 20 | 11279329 | Neuropsychiatric toxicity of antiviral treatment in chronic hepatitis C. | Dig Dis | 2000 | https://conductscience.org/library/papers/11279329 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/32905132/references